Abstract
IDF2022-0559 Efficacy and safety of empagliflozin as an add on to metformin and DPP4 inhibitor in T2DM patients, fasting during Ramadan
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
